dilating drops
Showing 1 - 25 of 1,068
Retinopathy of Prematurity Trial in Thessaloníki (Microdrop administration [phenylephrine 1.67% + tropicamide 0.33% (drop
Completed
- Retinopathy of Prematurity
- Microdrop administration [phenylephrine 1.67% + tropicamide 0.33% (drop volume: 6-7 μL)]
- Standard drop administration [phenylephrine 1.67% + tropicamide 0.33% (drop volume: 28-34 μL)]
-
Thessaloníki, Greece"Papageorgiou" General Hospital
Mar 23, 2022
Cataract Trial in Graz (Eye injection (Mydrane), eye drops (Phenylephrin), eye drops (Tropicamid))
Completed
- Cataract
- Eye injection (Mydrane)
- +2 more
-
Graz, AustriaMedical University Graz
Oct 11, 2021
Exotropia, Exophoria, Myopia Trial (0.01% atropine eye drops, eye drops (0.9% preservative free sodium chloride))
Not yet recruiting
- Exotropia
- +2 more
- 0.01% atropine eye drops
- placebo eye drops (0.9% preservative free sodium chloride)
- (no location specified)
May 17, 2022
Diabetes, Diabetic Retinopathy Trial in Butwal (Structured Counseling)
Completed
- Diabetes
- Diabetic Retinopathy
- Structured Counseling
-
Butwal, NepalLumbini Eye Institute and Research Center
Mar 9, 2022
Intraocular Pressure Trial in Winston-Salem (Brimonidine, Tropicamide, Phenylephrine Ophthalmic Product)
Completed
- Intraocular Pressure
- Brimonidine
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Medical Center
Jul 27, 2020
Retinopathy of Prematurity Trial in Thessaloníki (Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%,
Recruiting
- Retinopathy of Prematurity
- Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%
- Standard drop administration of phenylephrine 1.67% and tropicamide 0.33%
-
Thessaloníki, GreecePapageorgiou General Hospital
Oct 14, 2021
Children That Might be at Risk of Having Retinal Hemorrhages
Not yet recruiting
- Retinal Hemorrhage, Bilateral
- +2 more
- ophthalmoscopy and fundus photography through dilated pupills
- (no location specified)
Oct 18, 2022
Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)
Completed
- Dry Eye Syndrome
- rhNGF 20 µg/mL
- rhNGF 4 µg/mL
-
Wien, AustriaDepartment of Clinical Pharmacology
Dec 14, 2022
Type 2 Diabetes, Type 1 Diabetes Trial in Semnan (Tropicamide Ophthalmic)
Completed
- Type 2 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Tropicamide Ophthalmic
-
Semnan, Iran, Islamic Republic ofKowsar Semnan Research and Medical Training Center
Nov 18, 2021
Chromosome 18 Clinical Research Center
Recruiting
- Chromosome Aberrations
- +2 more
- Determination of growth hormone status
- +12 more
-
San Antonio, Texas
- +1 more
Nov 1, 2022
Cataract Trial in Verona (FIDIAL PLUS, IAL®-F)
Completed
- Cataract
- FIDIAL PLUS
- IAL®-F
-
Verona, ItalyAzienda Ospedaliera Universitaria Integrata di Verona
Sep 25, 2023
Infant, Newborn, Disease, Pain, Retinopathy of Prematurity Trial in Los Angeles (phototherapy eye shield)
Recruiting
- Infant, Newborn, Disease
- +3 more
- phototherapy eye shield
-
Los Angeles, CaliforniaChildren's Hospital Los Angeles
Mar 10, 2021
Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis Trial in Al Farwaniyah (cyclosporine A 0.05% eye drops)
Recruiting
- Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis
- cyclosporine A 0.05% eye drops
-
Al Farwānīyah, Farwanyia, KuwaitFarwanyia Hospital
Jan 31, 2023
Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)
Completed
- Glaucoma
- Ocular Hypertensive
- BRIDIN-plus Eye drops
- Combigan Eye drops
-
Seoul, Seongnam, Bundang-gu, Korea, Republic ofSeungsoo Rho
Oct 9, 2023
Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)
Recruiting
- Dry Eye Disease
- 0.09% cyclosporine A ophthalmic solution
-
Waterloo, Ontario, CanadaUniversity of Waterloo
Jul 13, 2023
Mesenchymal Stem Cell, Dry Eye Syndromes Trial (MSCs eye drops)
Not yet recruiting
- Mesenchymal Stem Cell
- Dry Eye Syndromes
- MSCs eye drops
- (no location specified)
Mar 13, 2023
Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry
Completed
- Dry Eye Disease
- modified hyaluronic acid 0.1% covalently linked to Riboflavin
- hyaluronic acid 0.1%
-
NAples, ItalyUniversity of Naples Federico II
Nov 2, 2023
Chronic Central Serous Chorioretinopathy Trial in Nijmegen, Rotterdam (steroid eye drops, Placebo)
Not yet recruiting
- Chronic Central Serous Chorioretinopathy
- steroid eye drops
- Placebo
-
Nijmegen, Netherlands
- +1 more
Nov 21, 2022
Glaucoma, Open-Angle Trial (Citicoline eye drops 2%, Placebo)
Not yet recruiting
- Glaucoma, Open-Angle
- Citicoline eye drops 2%
- Placebo
- (no location specified)
Feb 7, 2023
Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)
Recruiting
- Age-Related Macular Degeneration
- iPSC-derived RPE/PLGA transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 28, 2023
Cytomegalovirus Retinitis, Ganciclovir Eye Drops Trial in Tianjin (2% Ganciclovir Eye Drops)
Recruiting
- Cytomegalovirus Retinitis
- Ganciclovir Eye Drops
- 2% Ganciclovir Eye Drops
-
Tianjin, Tianjin, ChinaTianjin Medical University Eye Hospital
Jun 21, 2023
Neovascular Age-Related Macular Degeneration (nAMD) Trial in Worldwide (KHK4951, Aflibercept Injection)
Not yet recruiting
- Neovascular Age-Related Macular Degeneration (nAMD)
- KHK4951
- Aflibercept Injection
-
Arcadia, California
- +27 more
Oct 31, 2023
Diabetic Macular Edema (DME) Trial in Worldwide (KHK4951, Aflibercept Injection)
Not yet recruiting
- Diabetic Macular Edema (DME)
- KHK4951
- Aflibercept Injection
-
Arcadia, California
- +29 more
Oct 31, 2023
Dry Eye Syndromes, Sjogren Syndrome With Keratoconjunctivitis Trial in El Palomar (Amniotic membrane extract eye drops (AMEED))
Completed
- Dry Eye Syndromes
- Sjogren Syndrome With Keratoconjunctivitis
- Amniotic membrane extract eye drops (AMEED)
-
El Palomar, Buenos Aires, Argentina
- +2 more
Oct 24, 2022